Rep-max protein having anti-oncogenic activity and uses thereof

Details Rep-max protein having anti-oncogenic activity and uses thereof Rep-max protein having anti-oncogenic activity and uses thereof

1996-02-29

1998-09-22

Chambers, Jasemine C.

Chemistry: molecular biology and microbiology

Vector, per se

435 6, 4351723, 435 691, 935 57, 935 32, 935 34, C12N 1563, C12N 1579, C12N 1509

Patent

active

058112987

ABSTRACT:
The present invention provides a rep-max fusion gene which encodes a Rep-max protein capable of suppressing the oncogenic activity of a Myc family oncoprotein. The present invention further provides a vector containing nucleic acid encoding a Rep-max protein, a vector capable of expressing Rep-max protein and a recombinant viral vector capable of introducing nucleic acid encoding Rep-max protein into a target cell. Finally, the present invention provides a method for suppressing the oncogenic activity of Myc family oncoproteins in a tumor cell and for inhibiting the growth of a tumor in a subject.

REFERENCES:
Miller et al. (1995) FASEB J. 9:190-199.
Marshall, E (1995) Science 269:1050-1055.
Crystal R-G (1995) Science 270:404-410.

Affiliated with

Also associated with

Rating

Rep-max protein having anti-oncogenic activity and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rep-max protein having anti-oncogenic activity and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rep-max protein having anti-oncogenic activity and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1621285